PDCD1 and neoplasm: Cancer develops as tumor cells create subclones and strive to avoid immune surveillance via immune-silencing strategies such as the Programmed Cell Death 1 (PD1)/Programmed Cell Death 1 Ligand 1 (PDL1) blockade [21,22].